share_log

The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts

The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts

分析師觀點:在5位專家眼中的cardlytics
Benzinga ·  10/11 14:00
Cardlytics (NASDAQ:CDLX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Cardlytics(納斯達克股票代碼:CDLX)在上個季度接受了5位分析師的分析,顯示了從看好到看淡的各種觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
Analysts have recently evaluated Cardlytics and provided 12-month price targets. The average target is $4.9, accompanied by a high estimate of $7.00 and a low estimate of $3.50. A decline of 54.42% from the prior average price target is evident in the current average.
分析師最近評估了Cardlytics,並提供了12個月的價格目標。平均目標爲$4.9,最高估值爲$7.00,最低估值爲$3.50。當前平均價格目標較前者下跌了54.42%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級:更深入的了解
An in-depth analysis of recent analyst actions...
最近分析師行動的...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論